BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 8, 2002
View Archived Issues
Elan: 2001 review, 2002 projections
Read More
Pharmacological and clinical data on NXY-059 discussed in San Antonio
Read More
Selectin antagonist may have potential in the treatment of stroke according to rodent data
Read More
Addition of SM-20302 to tPA associated with beneficial outcome in thromboembolic stroke
Read More
Risk of thrombolysis-associated hemorrhage reduced by MMP inhibitor
Read More
CVS-3983: a promising lead inhibitor of the antitumor drug target matriptase
Read More
Antidepressant targeting GPCR enters human testing at Synaptic
Read More
Six-month follow-up results with OrCel treatment of venous ulcers
Read More
BSKB establishes Pyro Pharmaceuticals to handle new class of potential antibiotics
Read More
Long-term effects of CD154 blockade examined in experimental autoimmune encephalomyelitis
Read More
Bioenvision closes acquisition of Pathagon
Read More
Vion reports on progress in 2001
Read More
Texas Biotechnology 2001 report
Read More
BMS and Sanofi-Synthelabo withdraw irbesartan sNDA
Read More
Picovir NDA to be reviewed in March
Read More
Adolor conducts additional pivotal phase III trials of alvimopan in postoperative ileus
Read More
Pivotal trial of oral enoximone begins in advanced heart failure
Read More
Repligen and McLean Hospital collaborate on secretin studies in autism
Read More
Roche claims new compounds with utility in depression, etc.
Read More
Antitumor agents from Pfizer inhibit tyrosine kinases
Read More
Preparation and use of steroids for androgen- and estrogen-mediated diseases reported by Aventis
Read More
Scientists at Lilly synthesize inhibitors of multidrug resistance protein
Read More
PDE4 inhibitors in development at Sigma-Tau
Read More
Spanish lab designs selective muscarinic M3 receptor antagonists
Read More
Benzodiazepines with AMPA receptor-antagonist activity synthesized at Annovis
Read More